Definium Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$37.65

-2.67 (-6.62%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 23 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target +22.2% upside

Low Target $39.37

Average Target $46.00

High Target $57.04

Current Price $37.65

Current
$37.65

Target
$46.00

$39.37 $46.00 avg $57.04

Scenario Analysis

Bear Case

$39.37

4.6%

Low target

Base Case

$46.00

+22.2%

Avg target

Bull Case

$57.04

+51.5%

High target

Risk/Reward

11.3x

Highly favorable

Price in Context

52-Week High

$49.70

-24.2% from high

52-Week Low

$8.77

+329.2% from low

Target vs 52W High

$46.00

-7.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+11.8%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+10.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+7.0%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+19.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+185.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.8%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+198.7%